Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

499
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Chainsaw culture: Cladophialophora bantiana cerebral abscess after chainsaw activity in an immunocompetent host. Illustrative case.

Journal of neurosurgery. Case lessons·2026
Same author

Utility of dynamic <sup>18</sup>F-fluoroethyl-L-tyrosine positron emission tomography in determining pseudoprogression from tumor recurrence in the 6 months following radiation therapy for glioblastoma.

Neuro-oncology advances·2026
Same author

Glioblastoma mimicking anti-NMDA receptor encephalitis: a case series.

Internal medicine journal·2026
Same author

Real-world safety and effectiveness of ofatumumab in multiple sclerosis: A clinic-based study in Australia.

Multiple sclerosis journal - experimental, translational and clinical·2026
Same author

A Study of Time to Recovery Following Loss of Neuromonitoring Signal of the Recurrent Laryngeal Nerve in Thyroid Surgery.

World journal of surgery·2026
Same author

Safety and efficacy of B-cell therapy in older people with multiple sclerosis.

Frontiers in immunology·2026
Same journal

The paradox of peer review: protecting science or policing thought?

Internal medicine journal·2026
Same journal

Immune-related pancytopenia in pregnancy.

Internal medicine journal·2026
Same journal

Crossover effect: causal machine learning reveals opposing mortality responses to mean arterial pressure targets among phenotypically distinct hypertensive patients with septic shock.

Internal medicine journal·2026
Same journal

Clinicopathological findings, correlations and outcomes in patients with renal disease and living with antiretroviral-treated human immunodeficiency virus infection.

Internal medicine journal·2026
Same journal

Approach to thyroid disorders associated with immune checkpoint inhibitors and tyrosine kinase inhibitors.

Internal medicine journal·2026
Same journal

A scoping review of specialist hypertension clinics.

Internal medicine journal·2026
查看所有相关文章

相关实验视频

Updated: Jun 14, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

8.9K

多发性硬化症的进展

Turlough Montague1, James Drummond2, Karl Ng1,3

  • 1Department of Neurology, Royal North Shore Hospital, Sydney, New South Wales, Australia.

Internal medicine journal
|April 2, 2025
PubMed
概括
此摘要是机器生成的。

多发性硬化症 (MS) 管理正在推进,更新了诊断标准和用于早期干预的新生物标志物. 像CAR T细胞疗法和爱斯坦巴尔病毒 (EBV) 疫苗接种这样的创新疗法为进展性多发性硬化症患者提供了新的希望.

关键词:
这就是为什么MRI是MRI.多发性硬化症多发性硬化症神经免疫学 神经免疫学神经学 神经学 神经学

更多相关视频

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.4K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.9K

相关实验视频

Last Updated: Jun 14, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

8.9K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.4K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

57.9K

科学领域:

  • 神经学 神经学
  • 免疫学 免疫学 免疫学
  • 临床医学 临床医学

背景情况:

  • 多发性硬化症 (MS) 的全球患病率正在上升,需要早期诊断和干预以减少残疾.
  • 目前的治疗方法有效地降低了复发率,但MS的渐进性和退行性方面仍然存在重大挑战.
  • 现有的疾病修饰疗法正在随着更新的诊断标准和新兴生物标志物而发展.

研究的目的:

  • 为多发性硬化症提供全面的临床视角.
  • 为了突出MS诊断和治疗的最新进展.
  • 探索创新的治疗方向来管理MS.

主要方法:

  • 审查目前的MS临床实践和诊断标准.
  • 对MS患者护理优化新兴生物标志物的分析.
  • 探索新的治疗策略,包括基于细胞的疗法和疫苗接种.

主要成果:

  • 麦当劳诊断标准的更新提高了早期MS检测的敏感性.
  • 新型生物标志物显示出个性化多发性硬化护理和治疗优化的前景.
  • 诸如CAR T细胞疗法和EBV疫苗接种等创新疗法正在成为未来有希望的方向.

结论:

  • 早期诊断和治疗对于缓解MS相关残疾至关重要.
  • 诊断和生物标志物的进步正在促进及时干预.
  • 创新的免疫疗法代表了多发性硬化症未来管理的重大转变.